drugset / Trial / NCT00281255
Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
Phase 1/2
Withdrawn
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study will determine whether an acute infusion of intravenous allopurinol improves the inotropic response to dobutamine in patients with idiopathic dilated cardiomyopathy (DCM) as measured by cardiac magnetic resonance imaging (CMR).
Timeline
- Start
- 2003-06
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | — | Intravenous |
| Background | Dobutamine | Small molecule | — | — |